Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-10-20 Sale | 2021-10-22 9:42 pm | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director | 36,285 | $31.36 | $1,137,819 | 901,215 (Direct) | View |
| 2021-09-29 Sale | 2021-10-01 4:34 pm | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director | 29,256 | $27.89 | $815,863 | 937,500 (Direct) | View |
| 2021-09-27 Sale | 2021-09-29 4:05 pm | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director | 33,244 | $31.9 | $1,060,518 | 966,756 (Direct) | View |
| 2020-12-15 Purchase | 2020-12-17 9:15 pm | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 1,100,000 | $23 | $25,300,000 | 3,937,914 (Indirect) | View |
| 2020-12-15 Purchase | 2020-12-17 5:40 pm | 4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director | 100,000 | $23 | $2,300,000 | 100,000 (Indirect) | View |
| 2020-12-15 Purchase | 2020-12-17 5:40 pm | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 4,347 | $23 | $99,981 | 4,347 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-09-23 Option Award | 2022-09-27 5:08 pm | N/A 2032-09-22 | 4D Molecular Therapeutics Inc. | FDMT | Kasahara Noriyuki Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-09-23 Option Award | 2022-09-27 5:05 pm | N/A 2032-09-22 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz COO | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 8:42 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | FISHMAN ROBERT S Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 8:41 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J CFO | 60,000 | $0 | 62,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 8:40 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 8:38 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-06-16 Ownership | 2022-06-27 5:38 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 3,912,984 (Direct) | View |
| 2022-06-18 Option Award | 2022-06-21 7:54 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:08 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | Tomasello Shawn Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:06 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:05 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director | 33,750 | $0 | 33,750 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:02 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:01 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | GRAY SUSANNAH Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:00 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-03-21 Ownership | 2022-03-31 8:17 pm | N/A 2031-09-30 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 0 | $0 | 85,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 5:43 pm | N/A 2032-01-31 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J CFO | 65,000 | $0 | 67,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 5:42 pm | N/A 2032-01-31 | 4D Molecular Therapeutics Inc. | FDMT | Zimmermann Carolyne Chief Business Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 5:40 pm | N/A 2032-01-31 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David CEO 10% Owner | 150,000 | $0 | 2,150,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 5:39 pm | N/A 2032-01-31 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 70,000 | $0 | 70,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 5:39 pm | N/A 2032-01-31 | 4D Molecular Therapeutics Inc. | FDMT | FISHMAN ROBERT S Chief Medical Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-09 8:28 pm | N/A 2031-06-06 | 4D Molecular Therapeutics Inc. | FDMT | Zimmermann Carolyne Chief Business Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:36 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:34 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:33 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:33 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director | 33,750 | $0 | 33,750 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:32 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:31 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | Tomasello Shawn Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:30 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | GRAY SUSANNAH Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-04-12 Exercise | 2021-04-14 4:32 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J CFO | 1,000 | $9.41 | 225,060 (Direct) | View |
| 2021-04-12 Exercise | 2021-04-14 4:32 pm | N/A 2029-03-19 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J CFO | 1,000 | $0 | 225,060 (Direct) | View |
| 2021-03-08 Option Award | 2021-03-10 4:06 pm | N/A 2031-03-07 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-03-08 Option Award | 2021-03-10 4:05 pm | N/A 2031-03-07 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-03-08 Option Award | 2021-03-10 4:04 pm | N/A 2031-03-07 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J See Remarks | 70,000 | $0 | 70,000 (Direct) | View |
| 2020-12-15 Conversion | 2020-12-17 9:15 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 2,837,914 | $0 | 3,937,914 (Indirect) | View |